الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

major pharmaceuticals - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] , and in patients with: pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of hu

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

chartwell rx, llc - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations ( 8.4)] , nursing mothers [see use in specific populations ( 8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions ( 5.4)] - glaucoma [see adverse reactions ( 6.3) and drug interactions ( 7.1)] - obstructive uropathy [see warnings and precautions ( 5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions ( 5.5)] - severe ulcerative colitis [see warnings and precautions ( 5.7)] - reflux esophagitis pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/d

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy obstructive uropathy - obstructive disease of the gastrointestinal tract obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions) severe ulcerative colitis (see precautions) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage unstable cardiovascular status in acute hemorrhage - glaucoma glaucoma - myasthenia gravis myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients.) infants less than 6 months of age (see warnings and precautions: information for patients.) - nursing mothers (see warnings and precautions: information for patients). nursing mothers (see war

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

rebel distributors corp - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - for the treatment of functional bowel/irritable bowel syndrome. abuse of and/or dependence on dicyclomine for anticholinergic effects have been rarely reported.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

life line home care services, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy obstructive uropathy - obstructive disease of the gastrointestinal tract obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions) severe ulcerative colitis (see precautions) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage unstable cardiovascular status in acute hemorrhage - glaucoma glaucoma - myasthenia gravis myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients.) infants less than 6 months of age (see warnings and precautions: information for patients.) - nursing mothers (see warnings and precautions: information for patients). nursing mothers (see war

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions (5.4)] - glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] - obstructive uropathy [see warnings and precautions (5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] - severe ulcerative colitis [see warnings and precautions (5.7)] - reflux esophagitis pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to w

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

par pharmaceutical, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg in 5 ml - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [ see use in specific populations (8.4) ], nursing mothers [ see use in specific populations (8.3) ], and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [ see warnings and precautions (5.4) ] - glaucoma [ see adverse reactions (6.3) and drug interactions (7.1) ] - obstructive uropathy [ see warnings and precautions (5.8) ] - obstructive disease of the gastrointestinal tract [ see warnings and precautions (5.5) ] - severe ulcerative colitis [ see warnings and precautions (5.7) ] - reflux esophagitis adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. howev

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

mikart, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg in 5 ml - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4) ], nursing mothers [see use in specific populations (8.3) ], and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this dr

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

mylan institutional inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions (5.4)]

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

rebel distributors corp - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - dicyclomine hydrochloride tablets and capsules are indicated for the treatment of functional bowel/ irritable bowel syndrome. - obstructive uropathy - obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions ) - reflux esophagitis - unstable cardiovascular status in acute hemorrhage - glaucoma - myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients. ) - nursing mothers (see warnings and precautions: information for patients .) abuse of and/or dependence on dicyclomine for anticholinergic effects have been rarely reported.